The physiology, signaling, and pharmacology of dopamine receptors

Neurocircuitry of Addiction

Koob, G. F., & Volkow, N. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.110 · Cited by 5,340 · see citing works

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244 · see citing works

EVIDENCE FOR THE EXISTENCE OF MONOAMINE-CONTAINING NEURONS IN THE CENTRAL NERVOUS SYSTEM. I. DEMONSTRATION OF MONOAMINES IN THE CELL BODIES OF BRAIN STEM NEURONS.

Dahlstroem, A., & Fuxé, K. (1964) · PubMed · Cited by 5,143 · see citing works

Multiple receptors for dopamine

Kebabian, J. W., & Calne, D. B. (1979) · Nature · doi:10.1038/277093a0 · Cited by 3,742 · see citing works

Dopamine receptors: from structure to function

MISSALE, C., NASH, S. R., ROBINSON, S. W., JABER, M., & CARON, M. G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.189 · Cited by 3,633 · see citing works

Seven-transmembrane receptors

Pierce, K. L., Premont, R. T., & Lefkowitz, R. J. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm908 · Cited by 2,712 · see citing works

NEURAL MECHANISMS OF ADDICTION: The Role of Reward-Related Learning and Memory

Hyman, S. E., Malenka, R. C., & Nestler, E. J. (2006) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.113009 · Cited by 2,647 · see citing works

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

Sokoloff, P., Bruno Giros, A., Martres, M., Bouthenet, M.-L., & Schwartz, J. (1990) · Nature · doi:10.1038/347146a0 · Cited by 2,608 · see citing works

Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter

Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476 · see citing works

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220 · see citing works

A gene expression atlas of the central nervous system based on bacterial artificial chromosomes

Gong, S., Zheng, C., Doughty, M. L., Losos, K., Didkovsky, N., Schambra, U. B., Nowak, N. J., Joyner, A., Leblanc, G., Hatten, M. E., et al. (2003) · Nature · doi:10.1038/nature02033 · Cited by 2,108 · see citing works

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

Tol, H. H. M. V., Bunzow, J. R., Guan, H., Sunahara, R. K., Seeman, P. M., Niznik, H. B., & Civelli, O. (1991) · Nature · doi:10.1038/350610a0 · Cited by 2,015 · see citing works

Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry

Kravitz, A. V., Freeze, B. S., Parker, P. R. L., Kay, K., Thwin, M. T., Deisseroth, K., & Kreitzer, A. C. (2010) · Nature · doi:10.1038/nature09159 · Cited by 1,885 · see citing works

Verteilung Von Noradrenalin Und Dopamin (3-Hydroxytyramin) Im Gehirn Des Menschen Und Ihr Verhalten Bei Erkrankungen Des Extrapyramidalen Systems

Ehringer, H., & Hornykiewicz, O. (1960) · Journal of Molecular Medicine · doi:10.1007/bf01485901 · Cited by 1,875 · see citing works

Ionic dependence of glutamate neurotoxicity

Choi, D. W. (1987) · Journal of Neuroscience · doi:10.1523/jneurosci.07-02-00369.1987 · Cited by 1,854 · see citing works

Evolving Concepts in G Protein-Coupled Receptor Endocytosis: The Role in Receptor Desensitization and Signaling

Ferguson, S. S. G. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01478-9 · Cited by 1,827 · see citing works

Antipsychotic drug doses and neuroleptic/dopamine receptors

SEEMAN, P., LEE, T., CHAU-WONG, M., & WONG, K. (1976) · Nature · doi:10.1038/261717a0 · Cited by 1,622 · see citing works

Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration

Patrick, G. N., Zukerberg, L. R., Nikolić, M., de la Monte, S. M., Dikkes, P., & Tsai, L. (1999) · Nature · doi:10.1038/45159 · Cited by 1,541 · see citing works

The renaissance of GSK3

Cohen, P., & Frame, S. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096075 · Cited by 1,478 · see citing works

β-Arrestin-Dependent Formation of β 2 Adrenergic Receptor-Src Protein Kinase Complexes

Luttrell, L. M., Ferguson, S. S. G., Daaka, Y., Miller, W. E., Maudsley, S. R., Rocca, G. J. D., Lin, F., Kawakatsu, H., Owada, K. M., Luttrell, D. K., et al. (1999) · Science · doi:10.1126/science.283.5402.655 · Cited by 1,473 · see citing works

GSK3 takes centre stage more than 20 years after its discovery

FRAME, S., & COHEN, P. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590001 · Cited by 1,433 · see citing works

SIN1/MIP1 Maintains rictor-mTOR Complex Integrity and Regulates Akt Phosphorylation and Substrate Specificity

Jacinto, E., Facchinetti, V., Liu, D., Soto, N., Wei, S., Jung, S. Y., Huang, Q., Qin, J., & Su, B. (2006) · Cell · doi:10.1016/j.cell.2006.08.033 · Cited by 1,407 · see citing works

Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation

Hoeflich, K. P., Luo, J., Rubie, E. A., Tsao, M., Jin, O., & Woodgett, J. R. (2000) · Nature · doi:10.1038/35017574 · Cited by 1,394 · see citing works

G PROTEIN–COUPLED RECEPTOR KINASES

Pitcher, J. A., Freedman, N. J., & Lefkowitz, R. J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.653 · Cited by 1,379 · see citing works

3,4-Dihydroxyphenylalanine and 5-Hydroxytryptophan as Reserpine Antagonists

Carlsson, A., Lindqvist, M., & Magnusson, T. (1957) · Nature · doi:10.1038/1801200a0 · Cited by 1,272 · see citing works

β-Arrestin: a Protein that Regulates β-adrenergic Receptor Function

Lohse, M. J., Benovic, J., Codina, J., Caron, M. G., & Lefkowitz, R. J. (1990) · Science · doi:10.1126/science.2163110 · Cited by 1,222 · see citing works

Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1

Sunahara, R. K., Guan, H., O’Dowd, B. F., Seeman, P. M., Laurier, L. G., Ng, G., George, S. R., Torchia, J., Tol, H. H. M. V., & Niznik, H. B. (1991) · Nature · doi:10.1038/350614a0 · Cited by 1,166 · see citing works

Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia

Roth, B. L., Sheffler, D. J., & Kroeze, W. K. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1346 · Cited by 1,155 · see citing works

A translational profiling approach for the molecular characterization of CNS cell types

Heiman, M., Schaefer, A., Gong, S., Peterson, J. D., Day, M., Ramsey, K. E., Suárez-Fariñas, M., Schwarz, C., Stephan, D. A., Surmeier, D. J., et al. (2008) · Cell · doi:10.1016/j.cell.2008.10.028 · Cited by 1,134 · see citing works

The role of β-arrestins in the termination and transduction of G-protein-coupled receptor signals

Luttrell, L. M., & Lefkowitz, R. J. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.3.455 · Cited by 1,123 · see citing works

Functional Selectivity and Classical Concepts of Quantitative Pharmacology

Urban, J. D., Clarke, W. P., von Zastrow, M., Nichols, D. E., Kobilka, B. K., Weinstein, H., Javitch, J. A., Roth, B. L., Christopoulos, A., Sexton, P. M., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104463 · Cited by 1,119 · see citing works

Cloning and expression of a rat D2 dopamine receptor cDNA

Bunzow, J. R., Tol, H. H. M. V., Grandy, D. K., Albert, P. R., Salon, J. A., Christie, M. J., Machida, C. A., Neve, K. A., & Civelli, O. (1988) · Nature · doi:10.1038/336783a0 · Cited by 1,116 · see citing works

Enhanced Morphine Analgesia in Mice Lacking β-Arrestin 2

Bohn, L., Lefkowitz, R. J., Gainetdinov, R. R., Peppel, K., Caron, M. G., & Lin, F. (1999) · Science · doi:10.1126/science.286.5449.2495 · Cited by 1,079 · see citing works

Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia

Mohn, A. R., Gainetdinov, R. R., Caron, M. G., & Koller, B. H. (1999) · Cell · doi:10.1016/s0092-8674(00)81972-8 · Cited by 1,075 · see citing works

A decade of CDK5

Dhavan, R., & Tsai, L. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096019 · Cited by 1,052 · see citing works

Candidate gene studies of ADHD: a meta-analytic review

Gizer, I. R., Ficks, C., & Waldman, I. D. (2009) · Human Genetics · doi:10.1007/s00439-009-0694-x · Cited by 1,020 · see citing works

The Postsynaptic Architecture of Excitatory Synapses: A More Quantitative View

Sheng, M., & Hoogenraad, C. C. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.060805.160029 · Cited by 1,010 · see citing works

GSK3 takes centre stage more than 20 years after its discovery

Frame, S., & Cohen, P. (2001) · Biochemical Journal · doi:10.1042/bj3590001 · Cited by 997 · see citing works

Molecular biology of dopamine receptors

Sibley, D. R., & Monsma, F. J. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90025-2 · Cited by 993 · see citing works

Imaging dopamine's role in drug abuse and addiction

Volkow, N. D., Fowler, J. S., Wang, G. J., Baler, R., & Telang, F. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.05.022 · Cited by 988 · see citing works

Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs

Miyamoto, S., Duncan, G. E., Marx, C. E., & Lieberman, J. A. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001556 · Cited by 988 · see citing works

An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior

Beaulieu, J., Sotnikova, T. D., Marion, S., Lefkowitz, R. J., Gainetdinov, R. R., & Caron, M. G. (2005) · Cell · doi:10.1016/j.cell.2005.05.012 · Cited by 980 · see citing works

Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology

Shapiro, D. A., Renock, S. M., Arrington, E. G., Chiodo, L. A., Liu, L.-X., Sibley, D. R., Roth, B. L., & Mailman, R. B. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300203 · Cited by 971 · see citing works

Dopamine receptor pharmacology

Seeman, P. M., & Tol, H. H. M. V. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90323-9 · Cited by 969 · see citing works

Multiple dopamine D4 receptor variants in the human population

Tol, H. H. M. V., Wu, C. M., Guan, H.-C., Ohara, K., Bunzow, J. R., Civelli, O., Kennedy, J., Seeman, P., Niznik, H. B., & Jovanovic, V. (1992) · Nature · doi:10.1038/358149a0 · Cited by 955 · see citing works

μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence

Bohn, L., Gainetdinov, R. R., Lin, F., Lefkowitz, R. J., & Caron, M. G. (2000) · Nature · doi:10.1038/35047086 · Cited by 930 · see citing works

Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia

Emamian, E. S., Hall, D., Birnbaum, M. J., Karayiorgou, M., & Gogos, J. A. (2004) · Nature Genetics · doi:10.1038/ng1296 · Cited by 914 · see citing works

Application of a translational profiling approach for the comparative analysis of CNS cell types

Doyle, J. P., Dougherty, J. D., Heiman, M., Schmidt, E. F., Stevens, T. R., Ma, G., Bupp, S., Shrestha, P., Shah, R. D., Doughty, M. L., et al. (2008) · Cell · doi:10.1016/j.cell.2008.10.029 · Cited by 912 · see citing works

Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase.

Embi, N., Rylatt, D. B., & Cohen, P. (1980) · PubMed · Cited by 911 · see citing works

PKA phosphorylation of AMPA receptor subunits controls synaptic trafficking underlying plasticity

Esteban, J. A., Shi, S.-H., Wilson, C., Nuriya, M., Huganir, R. L., & Malinow, R. (2003) · Nature Neuroscience · doi:10.1038/nn997 · Cited by 894 · see citing works

Role of Serotonin in the Paradoxical Calming Effect of Psychostimulants on Hyperactivity

Gainetdinov, R. R., Wetsel, W. C., Jones, S. R., Levin, E. D., Jaber, M., & Caron, M. G. (1999) · Science · doi:10.1126/science.283.5400.397 · Cited by 885 · see citing works

The Neurobiology of Slow Synaptic Transmission

Greengard, P. (2001) · Science · doi:10.1126/science.294.5544.1024 · Cited by 865 · see citing works

DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS

Gainetdinov, R. R., Premont, R. T., Bohn, L., Lefkowitz, R. J., & Caron, M. G. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144206 · Cited by 864 · see citing works

Glycogen Synthase Kinase‐3 from Rabbit Skeletal Muscle

Noor, E. M. B. I., RYLATT, D. B., & Cohen, P. (1980) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1980.tb06059.x · Cited by 837 · see citing works

Dopamine Receptor Signaling

Neve, K. A., Seamans, J. K., & Trantham‐Davidson, H. (2004) · Journal of Receptors and Signal Transduction · doi:10.1081/rrs-200029981 · Cited by 836 · see citing works

Teaching old receptors new tricks: biasing seven-transmembrane receptors

Rajagopal, S., Rajagopal, K., & Lefkowitz, R. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3024 · Cited by 826 · see citing works

Structure and function of dopamine receptors

Vallone, D., Picetti, R., & Borrelli, E. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(99)00063-9 · Cited by 821 · see citing works

Demonstration and mapping out of nigro-neostriatal dopamine neurons

Andén, N. ‐., Carlsson, A., Dahlström, A. B., Fuxé, K., Hillarp, N. ‐., & Larsson, K. (1964) · Life Sciences · doi:10.1016/0024-3205(64)90161-4 · Cited by 812 · see citing works

Dopamine and retinal function

Witkovsky, P. (2004) · Documenta Ophthalmologica · doi:10.1023/b:doop.0000019487.88486.0a · Cited by 811 · see citing works

Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade

Beaulieu, J., Sotnikova, T. D., Yao, W., Kockeritz, L. K., Woodgett, J. R., Gainetdinov, R. R., & Caron, M. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307921101 · Cited by 792 · see citing works

Recent Advances in the Molecular Biology of Dopamine Receptors

Gingrich, J. A., & Caron, M. G. (1993) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.16.030193.001503 · Cited by 785 · see citing works

Disrupted in Schizophrenia 1 Regulates Neuronal Progenitor Proliferation via Modulation of GSK3β/β-Catenin Signaling

Mao, Y., Ge, X., Frank, C. L., Madison, J. M., Koehler, A. N., Doud, M. K., Tassa, C., Berry-Scott, E., Soda, T., Singh, K. K., et al. (2009) · Cell · doi:10.1016/j.cell.2008.12.044 · Cited by 768 · see citing works

Beyond the Dopamine Receptor

Greengard, P., Allen, P. B., & Nairn, A. C. (1999) · Neuron · doi:10.1016/s0896-6273(00)80798-9 · Cited by 748 · see citing works

Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence.

Carlsson, A., Waters, N., Holm-Waters, S., Tedroff, J., Nilsson, M., & Carlsson, M. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.237 · Cited by 742 · see citing works

The genetics of attention-deficit/hyperactivity disorder

Coghill, D., & Banaschewski, T. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.78 · Cited by 734 · see citing works

Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic

Zhou, Q.-Y., & Palmiter, R. D. (1995) · Cell · doi:10.1016/0092-8674(95)90145-0 · Cited by 731 · see citing works

Distinct functions of the two isoforms of dopamine D2 receptors

Usiello, A., Baik, J.-H., Rougé-Pont, F., Picetti, R., Dierich, A., LeMeur, M., Piazza, P. V., & Borrelli, E. (2000) · Nature · doi:10.1038/35041572 · Cited by 717 · see citing works

DARPP-32: An Integrator of Neurotransmission

Svenningsson, P., Nishi, A., Fisone, G., Girault, J., Nairn, A. C., & Greengard, P. (2004) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121415 · Cited by 711 · see citing works

Neurobiology of Schizophrenia

Ross, C. A., Margolis, R. L., Reading, S. A. J., Pletnikov, M. V., & Coyle, J. T. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.015 · Cited by 697 · see citing works

LTP Inhibits LTD in the Hippocampus via Regulation of GSK3β

Peineau, S., Taghibiglou, C., Bradley, C. A., Wong, T. P., Liu, L., Lu, J., Lo, E., Wu, D., Saule, E., Bouschet, T., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.029 · Cited by 690 · see citing works

Alternative splicing directs the expression of two D2 dopamine receptor isoforms

Bruno Giros, A., Sokoloff, P., Martres, M., Riou, J., Emorine, L. J., & Schwartz, J.-C. (1989) · Nature · doi:10.1038/342923a0 · Cited by 685 · see citing works

Molecular cloning and expression of the gene for a human D1 dopamine receptor

Dearry, A., Gingrich, J. A., Falardeau, P., Fremeau, R. T., Bates, M. D., & Caron, M. G. (1990) · Nature · doi:10.1038/347072a0 · Cited by 674 · see citing works

Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors

Baik, J., Picetti, R., Saiardi, A., Thiriet, G., Dierich, A., Depaulis, A., LeMeur, M., & Borrelli, E. (1995) · Nature · doi:10.1038/377424a0 · Cited by 651 · see citing works

Multiple D2 dopamine receptors produced by alternative RNA splicing

Monsma, F. J., McVittie, L. D., Gerfen, C. R., Mahan, L. C., & Sibley, D. R. (1989) · Nature · doi:10.1038/342926a0 · Cited by 641 · see citing works

Mechanisms of Amphetamine Action Revealed in Mice Lacking the Dopamine Transporter

Jones, S. R., Gainetdinov, R. R., Wightman, R. M., & Caron, M. G. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-06-01979.1998 · Cited by 626 · see citing works

Molecular Diversity of the Dopamine Receptors

Civelli, O., Bunzow, J. R., & Grandy, D. K. (1993) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.33.040193.001433 · Cited by 623 · see citing works

Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease

Lüscher, C., & Slesinger, P. A. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2834 · Cited by 617 · see citing works

Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum

Valjent, E., Pascoli, V., Svenningsson, P., Paul, S., Enslen, H., Corvol, J.-C., Stipanovich, A., Caboche, J., Lombroso, P. J., Nairn, A. C., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408305102 · Cited by 614 · see citing works

DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1

Hemmings, H. C., Greengard, P., Tung, H. Y. L., & Cohen, P. (1984) · Nature · doi:10.1038/310503a0 · Cited by 613 · see citing works

PKB/AKT: functional insights from genetic models

Scheid, M. P., & Woodgett, J. R. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096067 · Cited by 608 · see citing works

Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis

Swanson, J. M., Kinsbourne, M., Nigg, J., Lanphear, B., Stefanatos, G. A., Volkow, N., Taylor, E., Casey, B. J., Castellanos, F. X., & Wadhwa, P. D. (2007) · Neuropsychology Review · doi:10.1007/s11065-007-9019-9 · Cited by 580 · see citing works

Seven Transmembrane Receptors as Shapeshifting Proteins: The Impact of Allosteric Modulation and Functional Selectivity on New Drug Discovery

Kenakin, T., & Miller, L. J. (2010) · Pharmacological Reviews · doi:10.1124/pr.108.000992 · Cited by 573 · see citing works

Cloning and expression of human and rat Dt dopamine receptors

Zhou, Q., Grandy, D. K., Thambi, L., Kushner, J. A., Tol, H. H. M. V., Cone, R. D., Pribnow, D. G., Salon, J. A., Bunzow, J. R., & Civelli, O. (1990) · Nature · doi:10.1038/347076a0 · Cited by 562 · see citing works

Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons

Bibb, J. A., Snyder, G. L., Nishi, A., Yan, Z., Meijer, L., Fienberg, A. A., Tsai, L., Kwon, Y. T., Girault, J., Czernik, A. J., et al. (1999) · Nature · doi:10.1038/45251 · Cited by 553 · see citing works

Involvement of the Extracellular Signal-Regulated Kinase Cascade for Cocaine-Rewarding Properties

Valjent, E., Corvol, J., Pagès, C., Besson, M., Maldonado, R. J., & Caboche, J. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-23-08701.2000 · Cited by 548 · see citing works

Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction

Goldman-Rakic, P., Castner, S., Svensson, T., Siever, L., & Williams, G. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1793-y · Cited by 544 · see citing works

Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons

Chalecka-Franaszek, E., & Chuang, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8745 · Cited by 544 · see citing works

Dual Regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine d1 receptor

Lee, F. J. S., Xue, S., Pei, L., Vukusic, B., Chéry, N., Wang, Y., Wang, Y. T., Niznik, H. B., Yu, X.-M., & Liu, F. (2002) · Cell · doi:10.1016/s0092-8674(02)00962-5 · Cited by 542 · see citing works

Reward system and addiction: what dopamine does and doesn’t do

DiChiara, G., & Bassareo, V. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.11.003 · Cited by 534 · see citing works

Protein kinases that phosphorylate activated G protein‐coupled receptors

Premont, R. T., Inglese, J., & Lefkowitz, R. J. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.2.7781920 · Cited by 533 · see citing works

Decoding the Epigenetic Language of Neuronal Plasticity

Borrelli, E., Nestler, E. J., Allis, C. D., & Sassone‐Corsi, P. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.012 · Cited by 529 · see citing works

[The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia].

Birkmayer, W., & Hornykiewicz, O. (1961) · PubMed · Cited by 529 · see citing works

Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phosphatase inhibitors.

Andjelkovic, M., Jakubowicz, T., Cron, P., Ming, X., Han, J. W., & Hemmings, B. (1996) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.93.12.5699 · Cited by 525 · see citing works

Akt/GSK3 Signaling in the Action of Psychotropic Drugs

Beaulieu, J., Gainetdinov, R. R., & Caron, M. G. (2008) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145634 · Cited by 523 · see citing works

RGS Proteins and Signaling by Heterotrimeric G Proteins

Dohlman, H. G., & Thorner, J. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.7.3871 · Cited by 519 · see citing works

Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and ß-arrestin proteins

Claing, A. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00023-5 · Cited by 519 · see citing works

Dopamine: 50 years in perspective

Iversen, S. D., & Iversen, L. L. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.002 · Cited by 514 · see citing works

Molecular Diversity of the Dopamine Receptors

Civelli, O. (1993) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.33.1.281 · Cited by 510 · see citing works

Differential Kinetic and Spatial Patterns of β-Arrestin and G Protein-mediated ERK Activation by the Angiotensin II Receptor

Ahn, S., Shenoy, S. K., Wei, H., & Lefkowitz, R. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405878200 · Cited by 508 · see citing works

Mammalian RGS Proteins: Barbarians at the Gate

Berman, D. M., & Gilman, A. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.3.1269 · Cited by 497 · see citing works

Physiological Roles of G Protein–Coupled Receptor Kinases and Arrestins

Premont, R. T., & Gainetdinov, R. R. (2007) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.022405.154731 · Cited by 495 · see citing works

D1–D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of G q /11 in the striatum

Rashid, A. J., So, C. H., Kong, M. M. C., Furtak, T., El-Ghundi, M., Cheng, R., O’Dowd, B. F., & George, S. R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604049104 · Cited by 492 · see citing works

DARPP-32: Regulator of the Efficacy of Dopaminergic Neurotransmission

Fienberg, A. A., Hiroi, N., Mermelstein, P. G., Song, W., Snyder, G. L., Nishi, A., Chéramy, A., O'Callaghan, J. P., Miller, D. B., Cole, D. G., et al. (1998) · Science · doi:10.1126/science.281.5378.838 · Cited by 491 · see citing works

Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia

Miyakawa, T., Leiter, L. M., Gerber, D. J., Gainetdinov, R. R., Sotnikova, T. D., Zeng, H., Caron, M. G., & Tonegawa, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432926100 · Cited by 489 · see citing works

Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5

Bibb, J. A., Chen, J., Taylor, J. R., Svenningsson, P., Nishi, A., Snyder, G. L., Yan, Z., Sagawa, Z. K., Ouimet, C. C., Nairn, A. C., et al. (2001) · Nature · doi:10.1038/35066591 · Cited by 480 · see citing works

Epac: Defining a New Mechanism for cAMP Action

Gloerich, M., & Bos, J. L. (2010) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105714 · Cited by 476 · see citing works

Dopamine D1 and D2 Receptor Co-activation Generates a Novel Phospholipase C-mediated Calcium Signal

Lee, S. P., So, C. H., Rashid, A. J., Varghese, G. K., Cheng, R., Lança, A. J., O’Dowd, B. F., & George, S. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401923200 · Cited by 468 · see citing works

Molecular Substrates for Retrieval and Reconsolidation of Cocaine-Associated Contextual Memory

Miller, C. A., & Marshall, J. F. (2005) · Neuron · doi:10.1016/j.neuron.2005.08.006 · Cited by 467 · see citing works

Mice lacking the norepinephrine transporter are supersensitive to psychostimulants

Xu, F., Gainetdinov, R. R., Wetsel, W. C., Jones, S. R., Bohn, L., Miller, G. W., Wang, Y.-M., & Caron, M. G. (2000) · Nature Neuroscience · doi:10.1038/74839 · Cited by 464 · see citing works

Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation.

Monsma, F. J., Mahan, L. C., McVittie, L. D., Gerfen, C. R., & Sibley, D. R. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6723 · Cited by 456 · see citing works

Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-β-arrestin complexes after receptor endocytosis

Oakley, R. H., Laporte, S. A., Holt, J. A., Barak, L. S., & Caron, M. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101450200 · Cited by 455 · see citing works

Central amygdala ERK signaling pathway is critical to incubation of cocaine craving

Lu, L., Hope, B., Dempsey, J., Liu, S. Y., Bossert, J., & Shaham, Y. (2005) · Nature Neuroscience · doi:10.1038/nn1383 · Cited by 453 · see citing works

The Neurobiology of Dopamine Signaling

Girault, J., & Greengard, P. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.641 · Cited by 443 · see citing works

D₂Dopamine Receptors in Striatal Medium Spiny Neurons Reduce L-Type Ca²⁺Currents and Excitability via a Novel PLCβ1–IP₃–Calcineurin-Signaling Cascade

Hernández-López, S., Tkatch, T., Perez-Garci, E., Galarraga, E., Bargas, J., Hamm, H., & Surmeier, D. J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-08987.2000 · Cited by 443 · see citing works

Critical Involvement of cAMP/DARPP-32 and Extracellular Signal-Regulated Protein Kinase Signaling in L-DOPA-Induced Dyskinesia

Santini, E., Valjent, E., Usiello, A., Carta, M., Borgkvist, A., Girault, J., Hervé, D., Greengard, P., & Fisone, G. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0852-07.2007 · Cited by 436 · see citing works

Inhibitory Phosphorylation of Glycogen Synthase Kinase-3 (GSK-3) in Response to Lithium

Zhang, F., Phiel, C. J., Spece, L. J., Gurvich, N., & Klein, P. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212635200 · Cited by 436 · see citing works

Regulation of Akt and glycogen synthase kinase-3β phosphorylation by sodium valproate and lithium

Sarno, P. D., Li, X., & Jope, R. S. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00215-0 · Cited by 433 · see citing works

Direct protein–protein coupling enables cross-talk between dopamine D5 and γ-aminobutyric acid A receptors

Liu, F., Wan, Q., Pristupa, Z. B., Yu, X., Wang, Y. T., & Niznik, H. B. (2000) · Nature · doi:10.1038/35002014 · Cited by 430 · see citing works

Bidirectional Regulation of DARPP-32 Phosphorylation by Dopamine

Nishi, A., Snyder, G. L., & Greengard, P. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-21-08147.1997 · Cited by 424 · see citing works

Dopamine-Sensitive Adenyl Cyclase: Possible Role in Synaptic Transmission

Kebabian, J. W., & Greengard, P. (1971) · Science · doi:10.1126/science.174.4016.1346 · Cited by 422 · see citing works

The Akt–GSK-3 signaling cascade in the actions of dopamine

Beaulieu, J., Gainetdinov, R. R., & Caron, M. G. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.02.006 · Cited by 421 · see citing works

Glycogen Synthase Kinase-3β Haploinsufficiency Mimics the Behavioral and Molecular Effects of Lithium

O'Brien, W. T., Harper, A. D., Jove, F. A., Woodgett, J. R., Maretto, S., Piccolo, S., & Klein, P. S. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.4753-03.2004 · Cited by 415 · see citing works

Multifaceted roles of β-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling

Shenoy, S. K., & Lefkowitz, R. J. (2003) · Biochemical Journal · doi:10.1042/bj20031076 · Cited by 402 · see citing works

Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor

Sokoloff, P., Andrieux, M., Besançon, R., Pilon, C., Martres, M., Bruno Giros, A., & Schwartz, J.-C. (1992) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(92)90107-7 · Cited by 401 · see citing works

Genetics of dopamine receptors and drug addiction: a comprehensive review

Foll, B. L., Gallo, A., Strat, Y. L., Lü, L., & Gorwood, P. A. P. M. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283242f05 · Cited by 387 · see citing works

Increased D1 dopamine receptor signaling in levodopa‐induced dyskinesia

Aubert, I., Guigoni, C., Håkansson, K., Li, Q., Doveró, S., Barthe, N., Bioulac, B. H., Gross, C. E., Fisone, G., Bloch, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20296 · Cited by 386 · see citing works

Identification of PSD-95 as a Regulator of Dopamine-Mediated Synaptic and Behavioral Plasticity

Yao, W., Gainetdinov, R. R., Arbuckle, M. I., Sotnikova, T. D., Cyr, M., Beaulieu, J., Torres, G. E., Grant, S. G. N., & Caron, M. G. (2004) · Neuron · doi:10.1016/s0896-6273(04)00048-0 · Cited by 380 · see citing works

Dopamine D1 Receptor-Dependent Trafficking of Striatal NMDA Glutamate Receptors to the Postsynaptic Membrane

Dunah, A. W., & Standaert, D. G. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05546.2001 · Cited by 374 · see citing works

Beyond Desensitization: Physiological Relevance of Arrestin-Dependent Signaling

Luttrell, L. M., Gesty‐Palmer, D., & Sibley, D. R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002436 · Cited by 370 · see citing works

Role of GSK3β in behavioral abnormalities induced by serotonin deficiency

Beaulieu, J.-M., Zhang, X., Rodriguiz, R. M., Sotnikova, T. D., Cools, M. J., Wetsel, W. C., Gainetdinov, R. R., & Caron, M. G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711496105 · Cited by 368 · see citing works

β-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking

Kohout, T. A., Lin, F., Perry, S. J., Conner, D. A., & Lefkowitz, R. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1601 · Cited by 367 · see citing works

The evasive nature of drug efficacy: implications for drug discovery

Galandrin, S., Oligny-Longpré, G., & Bouvier, M. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.06.005 · Cited by 364 · see citing works

A β-arrestin 2 Signaling Complex Mediates Lithium Action on Behavior

Beaulieu, J., Marion, S., Rodriguiz, R. M., Medvedev, I. O., Sotnikova, T. D., Ghisi, V., Wetsel, W. C., Lefkowitz, R. J., Gainetdinov, R. R., & Caron, M. G. (2008) · Cell · doi:10.1016/j.cell.2007.11.041 · Cited by 362 · see citing works

Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D1A receptor.

Tiberi, M., Jarvie, K. R., Silvia, C. P., Falardeau, P., Gingrich, J. A., Godinot, N., Bertrand, L., Yang-Feng, T. L., Fremeau, R. T., & Caron, M. G. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7491 · Cited by 359 · see citing works

Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors

Bateup, H. S., Santini, E., Shen, W., Birnbaum, S. G., Valjent, E., Surmeier, D. J., Fisone, G., Nestler, E. J., & Greengard, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009874107 · Cited by 356 · see citing works

The molecular acrobatics of arrestin activation

Gurevich, V. V., & Gurevich, E. V. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.12.008 · Cited by 354 · see citing works

Dopamine supersensitivity correlates with D2 High states, implying many paths to psychosis

Seeman, P. M., Weinshenker, D., Quirion, R., Srivastava, L. K., Bhardwaj, S. K., Grandy, D. K., Premont, R. T., Sotnikova, T. D., Boksa, P., El-Ghundi, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409766102 · Cited by 353 · see citing works

ERK2: a logical AND gate critical for drug-induced plasticity?

Girault, J., Valjent, E., Caboche, J., & Hervé, D. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.08.012 · Cited by 348 · see citing works

Dopamine Partial Agonists

Lieberman, J. A. (2004) · CNS Drugs · doi:10.2165/00023210-200418040-00005 · Cited by 341 · see citing works

Transgenic Mice Overexpressing Glycogen Synthase Kinase 3β: A Putative Model of Hyperactivity and Mania

Prickaerts, J., Moechars, D., Cryns, K., Lenaerts, I., van Craenendonck, H., Goris, I., Daneels, G., Bouwknecht, J. A., & Steckler, T. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5216-05.2006 · Cited by 341 · see citing works

Essential role of β-adrenergic receptor kinase 1 in cardiac development and function

Jaber, M., Koch, W. J., Rockman, H. A., Smith, B. R., Bond, R. A., Sulik, K. K., Ross, J., Lefkowitz, R. J., Caron, M. G., & Bruno Giros, A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.12974 · Cited by 341 · see citing works

Molecular effects of dopamine on striatal-projection pathways

Gerfen, C. R. (2000) · Trends in Neurosciences · doi:10.1016/s1471-1931(00)00019-7 · Cited by 341 · see citing works

Deregulation of Cdk5 in a Mouse Model of ALS

Nguyen, M. D., Larivière, R., & Julien, J. (2001) · Neuron · doi:10.1016/s0896-6273(01)00268-9 · Cited by 339 · see citing works

G-protein-coupled receptor regulation: role of G-protein-coupled receptor kinases and arrestins

Ferguson, S. S. G., Barak, L. S., Zhang, J., & Caron, M. G. (1996) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-74-10-1095 · Cited by 330 · see citing works

The Dopamine D3 Receptor: A Therapeutic Target for the Treatment of Neuropsychiatric Disorders

Leriche, L., Bézard, E., Gross, C. E., Guillin, O., Foll, B. L., Díaz, J., & Sokoloff, P. (2006) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152706784111551 · Cited by 329 · see citing works

Heptahelical Receptor Signaling: Beyond the G Protein Paradigm

Hall, R. A., Premont, R. T., & Lefkowitz, R. J. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.145.5.927 · Cited by 325 · see citing works

Regulation of ERK ( Extracellular Signal Regulated Kinase), Part of the Neurotrophin Signal Transduction Cascade, in the Rat Mesolimbic Dopamine System by Chronic Exposure to Morphine or Cocaine

Berhow, M. T., Hiroi, N., & Nestler, E. J. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-15-04707.1996 · Cited by 323 · see citing works

Impact of complex genetic variation in COMT on human brain function

Meyer‐Lindenberg, A., Nichols, T. E., Callicott, J. H., Ding, J., Kolachana, B. S., Buckholtz, J. W., Mattay, V. S., Egan, M. F., & Weinberger, D. R. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001860 · Cited by 321 · see citing works

Antagonism of dopamine D2 receptor/β-arrestin 2 interaction is a common property of clinically effective antipsychotics

Masri, B., Salahpour, A., Didriksen, M., Ghisi, V., Beaulieu, J., Gainetdinov, R. R., & Caron, M. G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803522105 · Cited by 320 · see citing works

DISC1 regulates new neuron development in the adult brain via modulation of AKT-mTOR signaling through KIAA1212

Kim, J. Y., Duan, X., Liu, C. Y., Jang, M.-H., Guo, J. U., Pow-anpongkul, N., Kang, E., Song, H., & Ming, G.-L. (2009) · Neuron · doi:10.1016/j.neuron.2009.08.008 · Cited by 319 · see citing works

Heterotrimeric G proteins

Hamm, H. E., & Gilchrist, A. (1996) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(96)80065-2 · Cited by 317 · see citing works

AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test

Gould, T. D., Einat, H., Bhat, R. V., & Manji, H. K. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004535 · Cited by 314 · see citing works

Diverse Psychotomimetics Act Through a Common Signaling Pathway

Svenningsson, P., Tzavara, E. T., Carruthers, R., Rachleff, I., Wattler, S., Nehls, M. C., McKinzie, D. L., Fienberg, A. A., Nomikos, G. G., & Greengard, P. (2003) · Science · doi:10.1126/science.1089681 · Cited by 313 · see citing works

Differential Regulation of the Dopamine D2and D3 Receptors by G Protein-coupled Receptor Kinases and β-Arrestins

Kim, K., Valenzano, K. J., Robinson, S. W., Yao, W.-D., Barak, L. S., & Caron, M. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106728200 · Cited by 306 · see citing works

Targeting the dopamine D2receptor in schizophrenia

Seeman, P. M. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.4.515 · Cited by 304 · see citing works

In Vivo Regulation of Glycogen Synthase Kinase-3β (GSK3β) by Serotonergic Activity in Mouse Brain

Li, X., Zhu, W., Roh, M.-S., Friedman, A. B., Rosborough, K., & Jope, R. S. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300439 · Cited by 300 · see citing works

Parsing Molecular and Behavioral Effects of Cocaine in Mitogen- and Stress-Activated Protein Kinase-1-Deficient Mice

Brami‐Cherrier, K., Valjent, E., Hervé, D., Darragh, J., Corvol, J., Pagès, C., Simon, A. J., Girault, J., & Caboche, J. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1711-05.2005 · Cited by 294 · see citing works

G-protein-coupled receptor regulation: role of G-protein-coupled receptor kinases and arrestins

Ferguson, S. S. G., Barak, L. S., Zhang, J., & Caron, M. G. (1996) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y96-124 · Cited by 294 · see citing works

Dopamine receptor subtypes: beyond the D1/D2 classification

Andersen, P. H., Gingrich, J. A., Bates, M. D., Dearry, A., Falardeau, P., Senogles, S. E., & Caron, M. G. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90249-8 · Cited by 293 · see citing works

Regulation of BMAL1 Protein Stability and Circadian Function by GSK3β-Mediated Phosphorylation

Sahar, S., Zocchi, L., Kinoshita, C., Borrelli, E., & Sassone‐Corsi, P. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008561 · Cited by 291 · see citing works

Roles of the Akt/GSK-3 and Wnt Signaling Pathways in Schizophrenia and Antipsychotic Drug Action

Freyberg, Z., Ferrando, S. J., & Javitch, J. A. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.08121873 · Cited by 288 · see citing works

Judging a Protein by More Than Its Name: GSK-3

Woodgett, J. R. (2001) · Science s STKE · doi:10.1126/stke.2001.100.re12 · Cited by 279 · see citing works

7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity.

Kikuchi, T., Tottori, K., Uwahodo, Y., Hirose, T., Miwa, T., Oshiro, Y., & Morita, S. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10600-9 · Cited by 276 · see citing works

Calcium signaling cascade links dopamine D1–D2 receptor heteromer to striatal BDNF production and neuronal growth

Hasbi, A., Fan, T., Alijaniaram, M., Nguyen, T., Perreault, M. L., O’Dowd, B. F., & George, S. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903676106 · Cited by 274 · see citing works

G protein-coupled receptor kinase 4 gene variants in human essential hypertension

Felder, R. A., Sanada, H., Xu, J., Yu, P.-Y., Wang, Z., Watanabe, H., Asico, L. D., Wang, W., Zheng, S., Yamaguchi, I., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062694599 · Cited by 272 · see citing works

Dopamine Enhancement of NMDA Currents in Dissociated Medium-Sized Striatal Neurons: Role of D1 Receptors and DARPP-32

Flores‐Hernández, J., Cepeda, C., Hernández, E., Calvert, C. R., Jokel, E. S., Fienberg, A. A., Greengard, P., & Levine, M. S. (2002) · Journal of Neurophysiology · doi:10.1152/jn.00361.2002 · Cited by 270 · see citing works

Regulation of Akt Signaling by D2and D3Dopamine ReceptorsIn Vivo

Beaulieu, J., Tirotta, E., Sotnikova, T. D., Masri, B., Salahpour, A., Gainetdinov, R. R., Borrelli, E., & Caron, M. G. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.5074-06.2007 · Cited by 269 · see citing works

RGS9 Modulates Dopamine Signaling in the Basal Ganglia

Rahman, Z. U., Schwarz, J., Gold, S. J., Zachariou, V., Wein, M. N., Choi, K.-H., Kovoor, A., Chen, C.-K., Dileone, R., Schwarz, S. C., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00321-0 · Cited by 265 · see citing works

Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system.

Spano, P., Govoni, S. M., & Trabucchi, M. (1978) · PubMed · Cited by 264 · see citing works

The role of GSK‐3 in synaptic plasticity

Peineau, S., Bradley, C. A., Taghibiglou, C., Doherty, A., Bortolotto, Z. A., Wang, Y. T., & Collingridge, G. L. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.2 · Cited by 263 · see citing works

Physiological Modulation of Intestinal Motility by Enteric Dopaminergic Neurons and the D2 Receptor: Analysis of Dopamine Receptor Expression, Location, Development, and Function in Wild-Type and Knock-Out Mice

Li, Z., Schmauss, C., Cuenca, A., Ratcliffe, E., & Gershon, M. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.4720-05.2006 · Cited by 262 · see citing works

Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary.

Enjalbert, A., & Bockaert, J. (1983) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14305-8 · Cited by 262 · see citing works

Modulation of D2R-NR2B Interactions in Response to Cocaine

Liu, X., Chu, X., Mao, L., Wang, M., Lan, H.-X., Li, M., Zhang, G.-C., Parelkar, N. K., Fibuch, E. E., Haines, M. M., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.10.011 · Cited by 259 · see citing works

D 2 Dopamine Receptors Reduce N-Type Ca 2+ Currents in Rat Neostriatal Cholinergic Interneurons Through a Membrane-Delimited, Protein-Kinase-C-Insensitive Pathway

Yan, Z., Song, W., & Surmeier, D. J. (1997) · Journal of Neurophysiology · doi:10.1152/jn.1997.77.2.1003 · Cited by 259 · see citing works

Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC , encoding the calcineurin gamma subunit

Gerber, D. J., Hall, D., Miyakawa, T., Demars, S., Gogos, J. A., Karayiorgou, M., & Tonegawa, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432927100 · Cited by 258 · see citing works

Inhibition of mTOR Signaling in Parkinson’s Disease Prevents l -DOPA–Induced Dyskinesia

Santini, E., Heiman, M., Greengard, P., Valjent, E., & Fisone, G. (2009) · Science Signaling · doi:10.1126/scisignal.2000308 · Cited by 256 · see citing works

Intrarenal Dopamine: A Key Signal in the Interactive Regulation of Sodium Metabolism

Aperia, A. C. (2000) · Annual Review of Physiology · doi:10.1146/annurev.physiol.62.1.621 · Cited by 244 · see citing works

Potentiation of NMDA receptor currents by dopamine D 1 receptors in prefrontal cortex

Chen, G., Greengard, P., & Yan, Z. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308618100 · Cited by 243 · see citing works

Looking BAC at striatal signaling: cell-specific analysis in new transgenic mice

Valjent, E., Bertran‐Gonzalez, J., Hervé, D., Fisone, G., & Girault, J. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.06.005 · Cited by 241 · see citing works

A phosphatase cascade by which rewarding stimuli control nucleosomal response

Stipanovich, A., Valjent, E., Matamales, M., Nishi, A., Ahn, J., Maroteaux, M. J., Bertran‐Gonzalez, J., Brami‐Cherrier, K., Enslen, H., Corbillé, A.-G., et al. (2008) · Nature · doi:10.1038/nature06994 · Cited by 237 · see citing works

Activation of glycogen synthase kinase-3 inhibits long-term potentiation with synapse-associated impairments

Zhu, L.-Q., Wang, S.-H., Liu, D., Yin, Y.-Y., Tian, Q., Wang, X.-C., Wang, Q., Chen, J.-G., & Wang, J.-Z. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3321-07.2007 · Cited by 234 · see citing works

Regulation of Dopamine D1 Receptor Trafficking and Desensitization by Oligomerization with Glutamate N-Methyl-D-aspartate Receptors

Fiorentini, C., Gardoni, F., Spano, P., Luca, M. D., & Missale, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213140200 · Cited by 234 · see citing works

Cell type–specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs

Bateup, H. S., Svenningsson, P., Kuroiwa, M., Gong, S., Nishi, A., Heintz, N., & Greengard, P. (2008) · Nature Neuroscience · doi:10.1038/nn.2153 · Cited by 233 · see citing works

Drd1a-tdTomato BAC Transgenic Mice for Simultaneous Visualization of Medium Spiny Neurons in the Direct and Indirect Pathways of the Basal Ganglia

Shuen, J. A., Chen, M., Gloss, B. R., & Calakos, N. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.5492-07.2008 · Cited by 231 · see citing works

Distinct conformational changes in β-arrestin report biased agonism at seven-transmembrane receptors

Shukla, A. K., Violin, J. D., Whalen, E. J., Gesty‐Palmer, D., Shenoy, S. K., & Lefkowitz, R. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804246105 · Cited by 230 · see citing works

Dopaminergic Supersensitivity in G Protein-Coupled Receptor Kinase 6-Deficient Mice

Gainetdinov, R. R., Bohn, L., Sotnikova, T. D., Cyr, M., Laakso, A., Macrae, A. D., Torres, G. E., Kim, K.-M., Lefkowitz, R. J., Caron, M. G., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00192-2 · Cited by 229 · see citing works

Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition

Meyer‐Lindenberg, A., Straub, R. E., Lipska, B. K., Verchinski, B. A., Goldberg, T. E., Callicott, J. H., Egan, M. F., Huffaker, S., Mattay, V. S., Kolachana, B. S., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30413 · Cited by 226 · see citing works

Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances

Polter, A., Beurel, E., Yang, S., Garner, R., Song, L., Miller, C. A., Sweatt, J. D., McMahon, L., Bartolucci, A. A., Li, X., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.43 · Cited by 225 · see citing works

A Paradigm Shift in Brain Research

Carlsson, A. (2001) · Science · doi:10.1126/science.1066969 · Cited by 224 · see citing works

Cocaine-Induced Intracellular Signaling and Gene Expression Are Oppositely Regulated by the Dopamine D1 and D3 Receptors

Zhang, L., Lou, D., Jiao, H., Zhang, D., Wang, X., Xia, Y., Zhang, J., & Xu, M. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0060-04.2004 · Cited by 224 · see citing works

NEW INSIGHTS INTO DOPAMINERGIC RECEPTOR FUNCTION USING ANTISENSE AND GENETICALLY ALTERED ANIMALS

Sibley, D. R. (1999) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.313 · Cited by 224 · see citing works

Antipsychotic Drugs: Comparison in Animal Models of Efficacy, Neurotransmitter Regulation, and Neuroprotection

Lieberman, J. A., Bymaster, F. P., Meltzer, H. Y., Deutch, A. Y., Duncan, G. E., Marx, C. E., Aprille, J. R., Dwyer, D. S., Li, X., Mahadik, S. P., et al. (2008) · Pharmacological Reviews · doi:10.1124/pr.107.00107 · Cited by 223 · see citing works

Getting specialized: presynaptic and postsynaptic dopamine D2 receptors

Mei, C. D., Ramos, M., Iitaka, C., & Borrelli, E. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.12.002 · Cited by 220 · see citing works

The Role of Brain Dopamine in Behavioral Regulation and the Actions of Psychotropic Drugs

Snyder, S. H., Taylor, K. M., Coyle, J. T., et al. (1970) · American Journal of Psychiatry · doi:10.1176/ajp.127.2.199 · Cited by 218 · see citing works

Enhanced Rewarding Properties of Morphine, but not Cocaine, in βarrestin-2 Knock-Out Mice

Bohn, L., Gainetdinov, R. R., Sotnikova, T. D., Medvedev, I. O., Lefkowitz, R. J., Dykstra, L., & Caron, M. G. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-32-10265.2003 · Cited by 210 · see citing works

Regulation of Dopamine D1 Receptor Function by Physical Interaction with the NMDA Receptors

Pei, L., Lee, F. J. S., Moszczyńska, A., Vukusic, B., & Liu, F. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.3922-03.2004 · Cited by 209 · see citing works

The mesolimbic dopamine system as a target for rapid antidepressant action

Willner, P. (1997) · International Clinical Psychopharmacology · doi:10.1097/00004850-199707003-00002 · Cited by 209 · see citing works

Multiple human D5 dopamine receptor genes: a functional receptor and two pseudogenes.

Grandy, D. K., Zhang, Y. A., Bouvier, C., Zhou, Q. Y., Johnson, R. A., Allen, L., Buck, K. J., Bunzow, J. R., Salon, J. A., & Civelli, O. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.20.9175 · Cited by 209 · see citing works

GPCR functional selectivity has therapeutic impact

Mailman, R. B. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.06.002 · Cited by 208 · see citing works

Alteration in Kinase Activity But Not in Protein Levels of Protein Kinase B and Glycogen Synthase Kinase-3β in Ventral Prefrontal Cortex of Depressed Suicide Victims

Karege, F., Perroud, N. A., Burkhardt, S., Schwald, M., Ballmann, E., Harpe, R. L., & Malafosse, A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.04.036 · Cited by 208 · see citing works

Natural neural projection dynamics underlying social behavior

Gunaydin, L. A., Grosenick, L., Finkelstein, J. C., Kauvar, I. V., Fenno, L. E., Adhikari, A., Lammel, S., Mirzabekov, J. J., Airan, R. D., Zalocusky, K. A., et al. (2014) · Cell · doi:10.1016/j.cell.2014.05.017 · Cited by 1,389 · see citing works

Dopamine: Functions, Signaling, and Association with Neurological Diseases

Klein, M. O., Battagello, D. S., Cardoso, A. R., Hauser, D. N., Bittencourt, J. C., & Correa, R. G. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0632-3 · Cited by 1,073 · see citing works

Major depressive disorder: hypothesis, mechanism, prevention and treatment

Cui, L., Li, S., Wang, S., Wu, X., Liu, Y., Yu, W., Wang, Y., Tang, Y., Xia, M., & Li, B. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01738-y · Cited by 1,061 · see citing works

Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome

Yan, Y., Jiang, W., Liu, L., Wang, X., Ding, C., Tian, Z., & Zhou, R. (2015) · Cell · doi:10.1016/j.cell.2014.11.047 · Cited by 1,014 · see citing works

Dopaminergic modulation of synaptic transmission in cortex and striatum

Tritsch, N. X., & Sabatini, B. L. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.023 · Cited by 756 · see citing works

The Nucleus Accumbens: Mechanisms of Addiction across Drug Classes Reflect the Importance of Glutamate Homeostasis

Scofield, M. D., Heinsbroek, J. A., Gipson, C. D., Kupchik, Y. M., Spencer, S., Smith, A. C. W., Roberts-Wolfe, D., & Kalivas, P. W. (2016) · Pharmacological Reviews · doi:10.1124/pr.116.012484 · Cited by 598 · see citing works

The connectome of an insect brain

Winding, M., Pedigo, B. D., Barnes, C. L., Patsolic, H. G., Park, Y., Kazimiers, T., Fushiki, A., Andrade, I. V., Khandelwal, A., Valdes-Aleman, J., et al. (2023) · Science · doi:10.1126/science.add9330 · Cited by 435 · see citing works

Untitled work

Slominski (2012) · doi:10.1007/978-3-642-19683-6_1 · Cited by 461 · see citing works

Peripheral and central effects of circulating catecholamines

William Tank, A., & Lee Wong, D. (2014) · Comprehensive physiology · doi:10.1002/cphy.c140007 · Cited by 387 · see citing works

Oxytocin, motivation and the role of dopamine

Love, T. M. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.06.011 · Cited by 369 · see citing works

Chemotherapy in Psychiatry

Baldessarini, R. J. (2013) · doi:10.1007/978-1-4614-3710-9 · Cited by 365 · see citing works

Dopamine-Evoked Synaptic Regulation in the Nucleus Accumbens Requires Astrocyte Activity

Corkrum, M., Covelo, A., Lines, J., Bellocchio, L., Pisansky, M., Loke, K., Quintana, R., Rothwell, P. E., Lujan, R., Marsicano, G., et al. (2020) · Neuron · doi:10.1016/j.neuron.2019.12.026 · Cited by 327 · see citing works

Neuromodulation of Attention

Thiele, A., & Bellgrove, M. A. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.008 · Cited by 350 · see citing works

Computational psychiatry: towards a mathematically informed understanding of mental illness

Adams, R. A., Huys, Q. J. M., & Roiser, J. P. (2015) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-310737 · Cited by 285 · see citing works

Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings

Dichter, G. S., Damiano, C. A., & Allen, J. A. (2012) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-4-19 · Cited by 299 · see citing works

Reinforcement learning in depression: a review of computational research

Chen, C., Takahashi, T., Nakagawa, S., Inoue, T., & Kusumi, I. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.05.005 · Cited by 233 · see citing works

NOW vs LATER brain circuits: implications for obesity and addiction

Volkow, N. D., & Baler, R. D. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.04.002 · Cited by 237 · see citing works

Developmental origins of brain disorders: roles for dopamine

Money, K. M., & Stanwood, G. D. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00260 · Cited by 221 · see citing works

Optogenetic dissection of medial prefrontal cortex circuitry

Riga, D., Matos, M. R., Glas, A., Smit, A. B., Spijker, S., & Van den Oever, M. C. (2014) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2014.00230 · Cited by 208 · see citing works

The role of dopamine signaling in epileptogenesis

Bozzi, Y., & Borrelli, E. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00157 · Cited by 199 · see citing works

Neuromodulation in Tourette syndrome: dopamine and beyond

Buse, J., Schoenefeld, K., Münchau, A., & Roessner, V. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.10.004 · Cited by 185 · see citing works

Dopamine: A Modulator of Circadian Rhythms in the Central Nervous System

Korshunov, K. S., Blakemore, L. J., & Trombley, P. Q. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00091 · Cited by 173 · see citing works

Mechanisms of ketamine and its metabolites as antidepressants

Hess, E. M., Riggs, L. M., Michaelides, M., & Gould, T. D. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114892 · Cited by 169 · see citing works

Dopaminergic modulation of incentive motivation in adolescence: age-related changes in signaling, individual differences, and implications for the development of self-regulation

Luciana, M., Wahlstrom, D., Porter, J. N., & Collins, P. F. (2012) · Developmental Psychology · doi:10.1037/a0027432 · Cited by 156 · see citing works

Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse

Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148 · see citing works

Neuroglialpharmacology: Myelination as a shared mechanism of action of psychotropic treatments

Bartzokis, G. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.01.015 · Cited by 142 · see citing works

Dopaminergic transmission rapidly and persistently enhances excitability of D1 receptor-expressing striatal projection neurons

Lahiri, A. K., & Bevan, M. D. (2020) · Neuron · doi:10.1016/j.neuron.2020.01.028 · Cited by 133 · see citing works

Infectious agents and Alzheimer's disease

Piekut, T., Hurła, M., Banaszek, N., Szejn, P., Dorszewska, J., Kozubski, W., & Prendecki, M. (2022) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2102073 · Cited by 123 · see citing works

Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations

Cerovecki, A., Musil, R., Klimke, A., Seemüller, F., Haen, E., Schennach, R., Kühn, K.-U., Volz, H.-P., & Riedel, M. (2013) · CNS Drugs · doi:10.1007/s40263-013-0079-5 · Cited by 112 · see citing works

Neuromodulation of Hippocampal-Prefrontal Cortical Synaptic Plasticity and Functional Connectivity: Implications for Neuropsychiatric Disorders

Ruggiero, R. N., Rossignoli, M. T., Marques, D. B., de Sousa, B. M., Romcy-Pereira, R. N., Lopes-Aguiar, C., & Leite, J. P. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.732360 · Cited by 111 · see citing works

Testosterone induces molecular changes in dopamine signaling pathway molecules in the adolescent male rat nigrostriatal pathway

Purves-Tyson, T. D., Owens, S. J., Double, K. L., Desai, R., Handelsman, D. J., & Weickert, C. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091151 · Cited by 109 · see citing works

Peripheral and Central Effects of Circulating Catecholamines

William Tank, A., & Lee Wong, D. (2015) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2015.tb00599.x · Cited by 106 · see citing works

The steroid hormone 20-hydroxyecdysone binds to dopamine receptor to repress lepidopteran insect feeding and promote pupation

Kang, X.-L., Zhang, J.-Y., Wang, D., Zhao, Y.-M., Han, X.-L., Wang, J.-X., & Zhao, X.-F. (2019) · PLOS Genetics · doi:10.1371/journal.pgen.1008331 · Cited by 96 · see citing works

Therapeutic potential of targeting G protein-gated inwardly rectifying potassium (GIRK) channels in the central nervous system

Jeremic, D., Sanchez-Rodriguez, I., Jimenez-Diaz, L., & Navarro-Lopez, J. D. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107808 · Cited by 89 · see citing works

Pharmacological management of ocular hypertension: current approaches and future prospective

Bucolo, C., Salomone, S., Drago, F., Reibaldi, M., Longo, A., & Uva, M. G. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.09.012 · Cited by 71 · see citing works

Sympathoadrenergic modulation of hematopoiesis: a review of available evidence and of therapeutic perspectives

Cosentino, M., Marino, F., & Maestroni, G. J. M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00302 · Cited by 63 · see citing works

Effects of an Environmentally Relevant PFAS Mixture on Dopamine and Steroid Hormone Levels in Exposed Mice

Grønnestad, R., Johanson, S. M., Müller, M. H. B., Schlenk, D., Tanabe, P., Krøkje, Å., Jaspers, V. L. B., Jenssen, B. M., Ræder, E. M., Lyche, J. L., et al. (2021) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2021.115670 · Cited by 65 · see citing works

D1 and D5 dopamine receptors participate on the consolidation of two different memories

Furini, C. R. G., Myskiw, J. C., Schmidt, B. E., Marcondes, L. A., & Izquierdo, I. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.06.027 · Cited by 60 · see citing works

Prefrontal Dopaminergic Mechanisms of Extinction in Adolescence Compared to Adulthood in Rats

Zbukvic, I. C., Park, C. H. J., Ganella, D. E., Lawrence, A. J., & Kim, J. H. (2017) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2017.00032 · Cited by 57 · see citing works

Convergence of oxytocin and dopamine signalling in neuronal circuits: Insights into the neurobiology of social interactions across species

Rappeneau, V., & Castillo Díaz, F. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105675 · Cited by 51 · see citing works

A systematic review of licensed weight-loss medications in treating antipsychotic-induced weight gain and obesity in schizophrenia and psychosis.

Lee, K., Abraham, S., & Cleaver, R. (2022) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2022.07.006 · Cited by 53 · see citing works

Repurposing dopaminergic drugs for MS — the evidence mounts

Marino, F., & Cosentino, M. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.33 · Cited by 38 · see citing works

A mechanistic model of ADHD as resulting from dopamine phasic/tonic imbalance during reinforcement learning

Véronneau-Veilleux, F., Robaey, P., Ursino, M., & Nekka, F. (2022) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2022.849323 · Cited by 32 · see citing works

Dopamine Supersensitivity: A Novel Hypothesis of Opioid-Induced Neurobiological Mechanisms Underlying Opioid-Stimulant Co-use and Opioid Relapse

Strickland, J. C., Gipson, C. D., & Dunn, K. E. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.835816 · Cited by 31 · see citing works

From neurons to brain networks, pharmacodynamics of stimulant medication for ADHD

Parlatini, V., Bellato, A., Murphy, D., & Cortese, S. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105841 · Cited by 26 · see citing works

MicroRNAs in schizophrenia: implications for synaptic plasticity and dopamine–glutamate interaction at the postsynaptic density. New avenues for antipsychotic treatment under a theranostic perspective

de Bartolomeis, A., Iasevoli, F., Tomasetti, C., & Buonaguro, E. F. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8962-8 · Cited by 21 · see citing works

Identification of the Risk Genes Associated With Vulnerability to Addiction: Major Findings From Transgenic Animals

Jordan, C. J., & Xi, Z.-X. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.811192 · Cited by 20 · see citing works

Prior acoustic trauma alters type II afferent activity in the mouse cochlea

Nowak, N., Wood, M. B., Glowatzki, E., & Fuchs, P. A. (2021) · eneuro · doi:10.1523/eneuro.0383-21.2021 · Cited by 13 · see citing works

The Interplay Between Dopamine and Environment as the Biological Basis for the Early Origins of Mental Health

Barth, B., Portella, A. K., Dubé, L., Meaney, M. J., & Silveira, P. P. (2019) · Healthy Ageing and Longevity · doi:10.1007/978-3-030-24958-8_7 · Cited by 13 · see citing works

The clinical use of epigenetics in psychiatry: a narrative review of epigenetic mechanisms, key candidate genes, and precision psychiatry

Montel Hayes, R., Mason, C. E., & Miller, J. J. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1671122 · Cited by 5 · see citing works

Dopamine receptors and transporters : pharmacology, structure, and function

Niznik, H. B. (1994) · Cited by 74 · see citing works

Genetics of Childhood Disorders: XXII. ADHD, Part 6: The Dopamine D4 Receptor Gene

Barr, C. L. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200101000-00025 · Cited by 20 · see citing works

Modelling of Drug–Receptor Interactions: Stereoselectivity of 5-Hydroxytryptamine and Dopamine Receptors in the Brain

Hacksell, U., Johansson, A. M., Karlén, A., et al. (1990) · Elsevier eBooks · doi:10.1016/b978-0-12-136670-4.50011-4 · Cited by 2 · see citing works

Dopamine receptor genes: new tools for molecular psychiatry.

Niznik, H. B., & Tol, H. H. M. V. (1992) · PubMed Central · Cited by 91 · see citing works

Potentiation of the D2 mutant motor phenotype in mice lacking dopamine D2 and D3 receptors

Jung, M.-Y., Skryabin, B. V., Arai, M., Abbondanzo, S. J., Fu, D., Brosius, J., Robakis, N. K., Polites, H. G., Pintar, J. E., & Schmauss, C. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00705-2 · Cited by 130 · see citing works